
ARE Stock Forecast & Price Target
ARE Analyst Ratings
Bulls say
Alexandria Real Estate Equities Inc. benefits from a robust market presence in key life science hubs, supported by favorable demand trends in the public sector and a strategic focus on developing purpose-built spaces for life science and technology tenants. The company has a significant backlog of $10.8 billion in construction projects, highlighting strong growth potential in its construction segment, particularly in nuclear and civil operations. Additionally, the anticipated recovery in biotech valuations and the growth of technology, especially in AI sectors, could drive increased demand for lab space and further enhance Alexandria’s market position and profitability.
Bears say
The negative outlook on Alexandria Real Estate Equities Inc. stems from several critical factors, including a year-over-year decline in operating results attributed to reduced management and development fees and an end to certain contracts. Additionally, expectations of higher occupancy erosion and delays in asset sales, combined with a stagnation in demand from life science tenants, are projected to further pressure development leasing and earnings, especially as oversupply in the market intensifies due to inexperienced developers. The situation is exacerbated by slowed capital formation in the life sciences sector and regulatory challenges, significantly impacting the company's long-term financial viability and growth potential in the coming years.
This aggregate rating is based on analysts' research of Alexandria Real Estate Equities and is not a guaranteed prediction by Public.com or investment advice.
ARE Analyst Forecast & Price Prediction
Start investing in ARE
Order type
Buy in
Order amount
Est. shares
0 shares